Showing results 1 to 20 of 212
next >
Rights | Preview | Issue Date | Title | Author(s) | Type |
closedAccess |  | 2013 | A dominant-negative N-terminal fragment of HER2 frequently expressed in breast cancers | Morancho, B.; Pandiella, Atanasio CSIC ORCID CVN ; Arribas, Joaquín | artículo |
closedAccess |  | 2011 | A modular approach to trim cellular targets in anticancer drug discovery | Ríos-Luci, Carla; Díaz-Rodríguez, Elena CSIC ORCID CVN; Pandiella, Atanasio CSIC ORCID CVN | artículo |
openAccess |  | 18-Dec-2019 | A Transcriptomic Immunologic Signature Predicts Favorable Outcome in Neoadjuvant Chemotherapy Treated Triple Negative Breast Tumors | Pérez-Peña, Javier; Tibor Fekete, Janos; Páez, Raquel; Baliu-Piqué, Mariona; García-Saenz, José Ángel; García-Barberán, Vanesa; Manzano, Aranzazu CSIC ORCID ; Pérez-Segura, Pedro; Esparís-Ogando, Azucena CSIC ORCID CVN ; Pandiella, Atanasio CSIC ORCID CVN ; Győrffy, Balázs; Ocaña, Alberto | artículo |
closedAccess |  | 2005 | Activation of ErbB2 by overexpression or by transmembrane neuregulin results in differential signaling and sensitivity to herceptin | Yuste, Laura CSIC; Montero, Juan Carlos CSIC ORCID CVN; Esparís-Ogando, Azucena CSIC ORCID CVN ; Pandiella, Atanasio CSIC ORCID CVN | artículo |
openAccess |  | 2014 | Activation of the PI3K/mTOR/AKT pathway and survival in solid tumors: systematic review and meta-analysis | Ocaña, Alberto; Cuenca-López, María D.; Seruga, Bostjan; Pandiella, Atanasio CSIC ORCID CVN ; Amir, Eitan | artículo |
closedAccess |  | 2012 | Active kinase profiling, genetic and pharmacological data define mTOR as an important common target in triple-negative breast cancer | Montero, Juan Carlos CSIC ORCID CVN; Esparís-Ogando, Azucena CSIC ORCID CVN ; Re-Louhau, M. F. CSIC; Seoane, Samuel CSIC ORCID; Abad, María del Mar; Calero, R.; Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN | artículo |
openAccess |  | 30-Aug-2019 | Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer | Noblejas-López, María del Mar; Nieto-Jiménez, Cristina; Burgos, Miguel; Gómez-Juárez, Mónica; Montero, Juan Carlos CSIC ORCID CVN; Esparís-Ogando, Azucena CSIC ORCID CVN ; Pandiella, Atanasio CSIC ORCID CVN ; Galán-Moya, Eva María; Ocaña, Alberto | artículo |
closedAccess |  | 2020 | Adaptive resistance to trastuzumab impairs response to neratinib and lapatinib through deregulation of cell death mechanisms | Ríos-Luci, Carla; Díaz-Rodríguez, Elena CSIC ORCID CVN; Gandullo-Sánchez, Lucía CSIC ORCID; Díaz-Gil, Laura CSIC; Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN | artículo |
openAccess |  | 23-Mar-2022 | Additional file 1 of Surfaceome analyses uncover CD98hc as an antibody drug-conjugate target in triple negative breast cancer [Dataset] | Montero, Juan Carlos CSIC ORCID CVN; Calvo-Jiménez, Elisa; Carmen, Sofía del; Abad, María del Mar; Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN | dataset |
openAccess | | 23-Mar-2022 | Additional file 2 of Surfaceome analyses uncover CD98hc as an antibody drug-conjugate target in triple negative breast cancer [Dataset] | Montero, Juan Carlos CSIC ORCID CVN; Calvo-Jiménez, Elisa; Carmen, Sofía del; Abad, María del Mar; Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN | dataset |
openAccess | | 23-Mar-2022 | Additional file 3 of Surfaceome analyses uncover CD98hc as an antibody drug-conjugate target in triple negative breast cancer [Dataset] | Montero, Juan Carlos CSIC ORCID CVN; Calvo-Jiménez, Elisa; Carmen, Sofía del; Abad, María del Mar; Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN | dataset |
openAccess |  | Oct-2020 | Adoptive Cell Therapy in Breast Cancer: A Current Perspective of Next-Generation Medicine | Fuentes-Antrás, Jesús; Guevara-Hoyer, Kissy; Baliu-Piqué, Mariona; García-Saenz, José Ángel; Pérez-Segura, Pedro; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Alberto | artículo de revisión |
closedAccess |  | 17-May-2018 | Alteraciones transcripcionales en la vía de la ubiquitina-proteasoma (UPP) de células HER2+ resistentes a trastuzumab | Orive-Ramos, Ana CSIC; Pérez-Peña, Javier; Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN | comunicación de congreso |
openAccess |  | 2021 | Altered proTGFα/cleaved TGFα ratios offer new therapeutic strategies in renal carcinoma | García-Alonso, Sara; Romero-Pérez, Inés; Gandullo-Sánchez, Lucía CSIC ORCID; Chinchilla, Luis; Ocaña, Alberto; Montero, Juan Carlos CSIC ORCID CVN; Pandiella, Atanasio CSIC ORCID CVN | artículo |
openAccess |  | 1-Feb-2023 | An anti-EGFR antibody-drug conjugate overcomes resistance to HER2-targeted drugs | Gandullo-Sánchez, Lucía CSIC ORCID; Pandiella, Atanasio CSIC ORCID CVN | artículo |
openAccess |  | 2020 | An Overview of Antibody Conjugated Polymeric Nanoparticles for Breast Cancer Therapy | Juan, Alberto; Cimas, Francisco J.; Bravo, Iván; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Alberto; Alonso-Moreno, Carlos | artículo |
openAccess |  | 2012 | Androgen-independent prostate cancer cells circumvent EGFR inhibition by overexpression of alternative HER receptors and ligands | Carrión-Salip, Dolors; Pandiella, Atanasio CSIC ORCID CVN ; Massaguer, Anna | artículo |
openAccess |  | 21-Aug-2020 | Antibody Conjugation of Nanoparticles as Therapeutics for Breast Cancer Treatment | Juan, Alberto; Cimas, Francisco J.; Bravo, Iván; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Alberto; Alonso, Carlos CSIC | artículo |
closedAccess |  | 2016 | Antiproliferative effect of Synadenium grantii Hook f. stems (Euphorbiaceae) and a rare phorbol diterpene ester | Campos, Adriana; Barbosa Vendramini-Costa, Débora; Barbarini Longato, Giovanna; Tailyn Zermiani, Ana; Tasca Gois Ruiz, Lúcia; Carvalho, João Ernesto de; Pandiella, Atanasio CSIC ORCID CVN ; Cechinel Filho, Valdir | artículo |
openAccess |  | 2015 | Antitumor activity of the novel multi-kinase inhibitor EC-70124 in triple negative breast cancer | Cuenca-López, María D.; Serrano-Heras, Gemma CSIC ORCID; Montero, Juan Carlos CSIC ORCID CVN; Morales, Jorge C.; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Alberto | artículo |